Arkolith/Insider Trading/BBIO/Form 4

Kumar Neil

Chief Executive Officer, DirectorBridgeBio Pharma, Inc. (BBIO) · full profile →Form 4 · filed Aug 18, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
5 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 16, 2026Option exercise(M)34K——277K
Aug 16, 2026Option exercise(M)20K——296K
Aug 16, 2026Option exercise(M)12K——308K
Aug 16, 2026Option exercise(M)7K——315K
Aug 16, 2026Tax withholding(F)36K$79.86$2.9M278K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 16, 2026Option exercise(M)34K—$067K
Aug 16, 2026Option exercise(M)20K—$0118K
Aug 16, 2026Option exercise(M)12K—$0116K
Aug 16, 2026Option exercise(M)7K—$091K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001470831-26-000836) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for BridgeBio Pharma, Inc.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp